[1]Fu Yue,Liu Xinchun,Chen Qiuyang,Peng Yunpeng,Guo Song,Wei Jishu and Miao Yi.Expression of PARP14 in PDAC and its biological function[J].Acta Universitatis Medicinalis Nanjing,2017(8):932-937.

[2]JIANG Chong-yi,YUAN Zu-rong,WANG Wei,YIN Yu-lei,TU Yan-yuan,WANG Liu-bo.Expression of resistin in pancreatic ductal adenocarcinoma and its clinical significance[J].Journal of Surgery Concepts & Practice,2011,16(5):461-464.

[3]赵金钱,陈炯,方恒忠,杨旭东,朱兴兴,胡丕波.Expression of AQP8 in pancreatic ductal adenocarcinoma and its clinical significance[J].Acta Universitis Medicinalis Anhui,2018,53(2):284-287.

[4]Xiao Zhi,Wei Chen,Fei Xue,Chao Liang,Bryan Wei Chen,Yue Zhou,Liang Wen,Liqiang Hu,Jian Shen,Xueli Bai,Tingbo Liang.OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo[J].Oncotarget,2015,6(28):26230-26241.

[5]Jun Gao,Lihua Wang,Jinkang Xu,Jianming Zheng,Xiaohua Man,Hongyu Wu,Jin Jin,Kaixuan Wang,Huasheng Xiao,Shude Li,Zhaoshen Li.Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression[J].Journal of experimental & clinical cancer research : CR,2013,32(1):86.

[6]GAO Yang,ZHANG Shengning,ZHANG Xibing,MANG Yuanyi,LI Li,RAN Jianghua.Analysis of 93 cases of pancreatic ductal adenocarcinoma clinical prognosis[J].Contemporary Medicine,2021,27(3):1-6.

[7]Yuqi Sun,Shougen Cao,Zequn Li,Xiaodong Liu,Jinxiang Xu,Yulong Tian,Shuai Shen,Yanbing Zhou.A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC)[J].International journal of medical sciences,2021,18(9):2051.

[8]Yan Li,McFaul Christopher,Howes Nathan,Leslie Jane,Lancaster Gillian,Wong Theresa,Threadgold Jane,Evans Jonathan,Gilmore Ian,Smart Howard,Lombard Martin,Neoptolemos John,Greenhalf William.Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups[J].Gastroenterology,2005,128(7):2124-2130.

[9]Richard Drexler,Rebecca Fahy,Mirco Küchler,Kim C. Wagner,Tim Reese,Mareike Ehmke,Bernd Feyerabend,Moritz Kleine,Karl J. Oldhafer.Association of subcellular localization of TEAD transcription factors with outcome and progression in pancreatic ductal adenocarcinoma[J].Pancreatology,2021,21(1):170-179.

[10]Naidoo Kalnisha,Jones Richard,Dmitrovic Branko,Wijesuriya Nilukshi,Kocher Hemant,Hart Ian R,Crnogorac-Jurcevic Tatjana.Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases[J].The Journal of pathology,2012,226(5):756-763.

[11]Ali Gheysarzadeh,Hadi Bakhtiari,Amir Ansari,Amirnader Emami Razavi,Mohammad H. Emami,Mohammad R. Mofid.The insulin-like growth factor binding protein-3 and its death receptor in pancreatic ductal adenocarcinoma poor prognosis[J].Journal of cellular physiology,2019,234(12):23537-23546.

[12]Weiping Ji,Kailian Zheng,Bin Song,Ancheng Qin,Arvine Chandoo,Zhuo Shao,Jianwei Bi,Xiangqun Yang,Gang Jin,Xian Shen.OCIAD1 promoted pancreatic ductal adenocarcinoma migration by regulating ATM[J].Pancreatology,2019,19(5):751-759.

[13]Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis[J].Digestive and liver disease

[14]Jiayi Yan,Guanghui Chen,Xuesong Zhao,Fangying Chen,Ting Wang,Fei Miao.High expression of diffuse panbronchiolitis critical region 1 gene promotes cell proliferation,migration and invasion in pancreatic ductal adenocarcinoma[J].Biochemical and biophysical research communications,2018,495(2):1908-1914.

[15]Circulating IL-35 in pancreatic ductal adenocarcinoma patients[J].Human immunology

[16]Hao-Hong Shi,Hai-E Liu,Xing-Jing Luo.Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function[J].BMB reports,2020,53(12):658.

[17]Insulin-like growth factor binding protein 3 chemosensitizes pancreatic ductal adenocarcinoma through its death receptor[J].Pancreatology

[18]Jian-Yu Yang,Yong-Wei Sun,De-Jun Liu,Jun-Feng Zhang,Jiao Li,Rong Hua.MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer[J].American journal of cancer research,2014,4(6):663-673.

[19]Qian Zhan,Xiaxing Deng,Yuanchi Weng,Jiabin Jin,Zhichong Wu,Hongwei Li,Baiyong Shen,Chenghong Peng.Outcomes of robotic surgery for pancreatic ductal adenocarcinoma[J].Chinese Journal of Cancer Research,2015,27(6):604-610.

[20]The molecular landscape of pancreatic ductal adenocarcinoma[J].Pancreatology